Foundation Welcomed into Million Dollar Council for On Deck for the Cure® Walk Donations
SANTA CLARITA, Calif. (January 11, 2012) — The Princess Cruises Community Foundation and Susan G. Komen for the Cure® have announced a new three-year partnership for two research projects supporting the fight against breast cancer.
One of the Foundation-supported research grants, at the University of California at Los Angeles (UCLA), will look at the molecular effects of the chemical BPA on breast cancer, while the other, at Stanford University School of Medicine, will study breast stem cell differentiation.
The projects are funded by the Princess Cruises Community Foundation’s On Deck for the Cure® program, which is a 5K fundraising walk for passengers held during the course of every Princess cruise. At the same time, the Foundation has been welcomed into the Komen Million Dollar Council for surpassing this donation milestone.
“These two research projects are both important steps toward finding causes and treatments for breast cancer,” said Alan Buckelew, president of the Princess Cruises Community Foundation, and also president and CEO of Princess Cruises. “Reaching the million dollar donation level and being able to fund this work underscores our commitment to this cause, and we want to acknowledge the support of our passengers for this important milestone. On every cruise, they take time out of their vacation to circle the decks, raising both funds and awareness to fight one of the leading causes of death for women in the U.S.”
The research supported by Susan G. Komen with funding from the Princess Cruises Community Foundation’s On Deck for the Cure program includes:
Determining the Molecular Effects of Bisphenol A (BPA) in Mammary Gland Stem Cells and Breast Cancer Proliferation
Headed by Dr. Susan Krum at UCLA, this study will investigate whether a chemical known as Bisphenol A (BPA) — commonly found in plastic containers, ranging from baby bottles to food containers — causes or accelerates breast cancer. BPA is similar to the hormone estrogen, which is responsible for stimulating the growth of a large percentage of breast cancers. Dr. Krum and her colleagues will test whether BPA, acting like estrogen, may also stimulate tumor growth.
Functional Analysis of the DLK1-GTL2 Imprinted Region in Breast Stem Cell Differentiation and Tumorigenesis
Dr. Michael Clarke heads this Stanford University School of Medicine study to attempt to determine whether small RNA molecules (MicroRNA) from a specific region in breast stem cells can be used to treat or predict breast cancer. The study will also investigate whether restoring irregular MicroRNA in breast cancer cells can prevent tumor growth.
“Princess Cruises Community Foundation is a committed partner in the fight against breast cancer,” said Katrina McGhee, CMO & executive vice president for Susan G. Komen for the Cure. “Not only do they raise awareness on board every ship during every sailing, they also raise significant funds to help Susan G. Komen fulfill our promise to end breast cancer forever. We are so grateful to Princess Cruises Community Foundation and the Princess employees and guests for their dedication to our cause.”
Since the On Deck for the Cure program was launched on Princess ships in 2007, thousands of passengers have participated in the fundraising walks held during the course of each cruise. The five-kilometer walks around the ships’ decks always draw an enthusiastic group of passengers who donate a minimum of $15 to participate, and receive a special hat, and a post-walk appreciation reception.
# # #
About Susan G. Komen for the Cure®:
Nancy G. Brinker promised her dying sister, Susan G. Komen, that she would do everything in her power to end breast cancer. Today, Susan G. Komen for the Cure works to end breast cancer in the U.S. and throughout the world through ground-breaking research, community health outreach, advocacy and programs in more than 50 countries with a special focus on low-resource and developing nations. Visit komen.org. Connect with us on Facebook and Twitter.